GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 191 filers reported holding GERON CORP in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43,289 | -95.3% | 19,949 | -94.8% | 0.00% | -100.0% |
| Q4 2022 | $921,553 | -19.9% | 380,807 | -22.5% | 0.00% | 0.0% |
| Q3 2022 | $1,150,000 | +1413.2% | 491,296 | +908.4% | 0.00% | – |
| Q2 2022 | $76,000 | -41.5% | 48,718 | -54.1% | 0.00% | – |
| Q4 2021 | $130,000 | -27.0% | 106,163 | -18.2% | 0.00% | – |
| Q3 2021 | $178,000 | -31.5% | 129,818 | -29.7% | 0.00% | – |
| Q2 2021 | $260,000 | +170.8% | 184,661 | +127.8% | 0.00% | -100.0% |
| Q1 2020 | $96,000 | -65.2% | 81,056 | -60.1% | 0.00% | -50.0% |
| Q4 2019 | $276,000 | +2.6% | 203,225 | +0.4% | 0.00% | 0.0% |
| Q3 2019 | $269,000 | -17.2% | 202,458 | -12.1% | 0.00% | -33.3% |
| Q2 2019 | $325,000 | -21.5% | 230,365 | -7.6% | 0.00% | -40.0% |
| Q1 2019 | $414,000 | +89.9% | 249,368 | +14.7% | 0.01% | +150.0% |
| Q4 2018 | $218,000 | -47.8% | 217,497 | +78.6% | 0.00% | -50.0% |
| Q2 2018 | $418,000 | -32.0% | 121,785 | -64.4% | 0.00% | 0.0% |
| Q4 2017 | $615,000 | +8.1% | 341,863 | +30.9% | 0.00% | -20.0% |
| Q3 2017 | $569,000 | -32.7% | 261,128 | -14.4% | 0.01% | -44.4% |
| Q2 2017 | $845,000 | +74.2% | 304,912 | +42.7% | 0.01% | +50.0% |
| Q1 2017 | $485,000 | +34.7% | 213,680 | +34.2% | 0.01% | +50.0% |
| Q3 2016 | $360,000 | -47.4% | 159,212 | -37.6% | 0.00% | -50.0% |
| Q2 2016 | $684,000 | +10.3% | 255,251 | +20.2% | 0.01% | -11.1% |
| Q1 2016 | $620,000 | -66.8% | 212,390 | -44.9% | 0.01% | -59.1% |
| Q4 2015 | $1,867,000 | +59.8% | 385,707 | -8.9% | 0.02% | +37.5% |
| Q3 2015 | $1,168,000 | -9.9% | 423,166 | +39.7% | 0.02% | -11.1% |
| Q2 2015 | $1,296,000 | +19.8% | 302,849 | +5.5% | 0.02% | +5.9% |
| Q1 2015 | $1,082,000 | +8.4% | 287,105 | -6.5% | 0.02% | +13.3% |
| Q4 2014 | $998,000 | +46.1% | 307,200 | -10.0% | 0.02% | +36.4% |
| Q3 2014 | $683,000 | -10.5% | 341,503 | +43.7% | 0.01% | -8.3% |
| Q2 2014 | $763,000 | -24.9% | 237,732 | -51.3% | 0.01% | -29.4% |
| Q1 2014 | $1,016,000 | -34.9% | 488,274 | +48.3% | 0.02% | -29.2% |
| Q4 2013 | $1,560,000 | +132.5% | 329,210 | +64.3% | 0.02% | +84.6% |
| Q3 2013 | $671,000 | +886.8% | 200,374 | +344.5% | 0.01% | +550.0% |
| Q2 2013 | $68,000 | – | 45,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,623,889 | $6,861,000 | 1.25% |
| RA Capital Management | 30,126,299 | $36,754,000 | 0.65% |
| NEA Management Company, LLC | 13,461,538 | $16,423,000 | 0.33% |
| Virtus ETF Advisers LLC | 128,325 | $157,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 227,163 | $277,000 | 0.04% |
| Forefront Analytics, LLC | 84,536 | $103,000 | 0.03% |
| Poehling Capital Management, INC. | 54,000 | $66,000 | 0.02% |
| Summit X, LLC | 71,297 | $86,000 | 0.02% |
| Vishria Bird Financial Group, LLC | 20,615 | $25,000 | 0.01% |
| Piscataqua Savings Bank | 12,500 | $15,000 | 0.01% |